Table 1. Demographic and the Baseline Clinical Characteristics.
| Characteristic | No. (%) of patients (N = 842) |
|---|---|
| Age, y | |
| ≤60 | 391 (46.4) |
| >60 | 451 (53.6) |
| Sex | |
| Male | 513 (60.9) |
| Female | 329 (39.1) |
| Tumor size, cm | |
| ≤5 | 380 (45.1) |
| >5 | 462 (54.9) |
| Multinodular | |
| Single | 134 (15.9) |
| Multiple | 708 (84.1) |
| BCLC stage | |
| A | 109 (12.9) |
| B | 519 (61.7) |
| C | 214 (25.4) |
| Serum AFP, ng/mL | |
| ≤400 | 244 (29.0) |
| >400 | 598 (71.0) |
| HDQTI score | |
| 34 | 570 (67.7) |
| ≥34 | 272 (32.3) |
Abbreviations: AFP, α1-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; HDQTI, hepatitis B virus DNA quantitation-time index.
SI conversion factors: To convert AFP to micrograms per liter, multiply by 1.